Combination of Saxagliptin and Metformin Is Effective as Initial Therapy in Type 2 Diabetes Mellitus (T2DM) With Severe Hyperglycemia

被引：0
|
作者：
Babu, Ambika
Barcham, Samih
Daniel, Louis
Fogelfeld, Leon
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1059-P
引用
收藏
页码：A273 / A273
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of saxagliptin in combination with metformin compared with sitagliptin in combination with metformin in adult patients with type 2 diabetes mellitus
    Scheen, Andre J.
    Charpentier, Guillaume
    Ostgren, Carl Johan
    Hellqvist, Asa
    Gause-Nilsson, Ingrid
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2010, 26 (07) : 540 - 549
  • [42] Graft of Microencapsulated Sertoli Cells for the Cell Therapy of Type 2 Diabetes Mellitus (T2DM)
    Luca, Giovanni
    Mancuso, Francesca
    Calvitti, Mario
    Arato, Iva
    Falabella, Giulia
    Bobo, Mariella
    Beccetti, Ennio
    Calafiore, Riccardo
    TRANSPLANTATION, 2013, 96 (06) : S116 - S116
  • [43] BENEFITS AND RISKS OF VILDAGLIPTIN/METFORMIN VERSUS SULPHONYLUREAS/METFORMIN COMBINATION THERAPY IN TYPE 2 DIABETES MELLITUS (T2DM) FROM PATIENT'S PERSPECTIVE: REAL-WORLD DATA
    Ionova, T.
    Nikitina, T.
    Kurbatova, K.
    Rodionova, A.
    VALUE IN HEALTH, 2015, 18 (07) : A615 - A615
  • [44] Addition of Alogliptin vs Uptitration of Pioglitazone Dose in Type 2 Diabetes Mellitus (T2DM) Patients on Metformin Plus Pioglitazone Therapy
    Bosi, Emanuele
    Ellis, Graham
    Moneuse, Patrick
    Wilson, Craig
    Fleck, Penny
    DIABETES, 2010, 59 : A148 - A148
  • [45] Efficacy and Safety of Saxagliptin plus Metformin as Initial Therapy in Patients with Type 2 Diabetes
    Dou, Jingtao
    Ma, Jianhua
    Liu, Jun
    Wang, Changjiang
    Johnsson, Eva
    Yao, Yolanda
    Zhao, June
    Pan, Changyu
    DIABETES, 2017, 66 : A327 - A327
  • [46] Initial combination therapy with sitagliptin and metformin provides effective and durable glycaemic control over I year in patients with type 2 diabetes (T2DM): A pivotal phase III clinical trial
    Williams-Herman, D. E.
    Johnson, J. R.
    Lunceford, J. K.
    DIABETOLOGIA, 2007, 50 : S52 - S53
  • [47] Does obesity cause type 2 diabetes mellitus (T2DM)? Or is it the opposite?
    Malone, John I.
    Hansen, Barbara C.
    PEDIATRIC DIABETES, 2019, 20 (01) : 5 - 9
  • [48] Altered bile salt metabolism in type 2 diabetes mellitus (T2DM)
    Brufau, Gemma
    Kuipers, Folkert
    Prado, Kris
    Abbey, Stacey
    Jones, Michael
    Schwartz, Sherwyn
    Stellaard, Frans
    Murphy, Elizabeth
    DIABETES, 2008, 57 : A435 - A435
  • [49] Bayesian nonparametric comorbidity analysis of type 2 diabetes mellitus (T2DM)
    De la Torre, Adrian Martinez
    Perez-Cruz, Fernando
    Weiler, Stefan
    Burden, Andrea
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 503 - 504
  • [50] The predicted mechanisms and evidence of probiotics on type 2 diabetes mellitus (T2DM)
    Bajinka, Ousman
    Sylvain Dovi, Kodzovi
    Simbilyabo, Lucette
    Conteh, Ishmail
    Tan, Yurong
    ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 2024, 130 (04) : 475 - 490
12345